3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide

C37H39N5O8 — CID 11115100

IUPAC3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide
SMILESCOc1ccc(C(OC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)(c2ccc(OC)cc2)c2cccc(C(=O)NCCn3ccnc3)c2)cc1
InChIInChI=1S/C37H39N5O8/c1-24-21-42(36(46)40-34(24)44)33-20-31(43)32(50-33)22-49-37(26-7-11-29(47-2)12-8-26,27-9-13-30(48-3)14-10-27)28-6-4-5-25(19-28)35(45)39-16-18-41-17-15-38-23-41/h4-15,17,19,21,23,31-33,43H,16,18,20,22H2,1-3H3,(H,39,45)(H,40,44,46)/t31-,32+,33+/m0/s1
InChIKeyCYCQYSQIDNJRHV-WIHCDAFUSA-N
MW681.75 g/mol
LogP3.15
Rot. Bonds13

About 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide

3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide (PubChem CID 11115100) has the molecular formula C37H39N5O8 and a molecular weight of 681.75 g/mol. Its IUPAC name is 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide.

Molecular Properties

Compound Name3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide
PubChem CID11115100
Molecular FormulaC37H39N5O8
Molecular Weight681.75 g/mol
Exact Mass681.28
IUPAC Name3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide
SMILESCOc1ccc(C(OC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)(c2ccc(OC)cc2)c2cccc(C(=O)NCCn3ccnc3)c2)cc1
InChIInChI=1S/C37H39N5O8/c1-24-21-42(36(46)40-34(24)44)33-20-31(43)32(50-33)22-49-37(26-7-11-29(47-2)12-8-26,27-9-13-30(48-3)14-10-27)28-6-4-5-25(19-28)35(45)39-16-18-41-17-15-38-23-41/h4-15,17,19,21,23,31-33,43H,16,18,20,22H2,1-3H3,(H,39,45)(H,40,44,46)/t31-,32+,33+/m0/s1
InChIKeyCYCQYSQIDNJRHV-WIHCDAFUSA-N
XLogP3.15
TPSA158.93 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds13
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500681.75
LogP ≤ 53.15
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Analyze 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide?
The IUPAC name of 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide (CID 11115100) is 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide.
What is the SMILES notation for 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide?
The canonical SMILES for 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide is COc1ccc(C(OC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)(c2ccc(OC)cc2)c2cccc(C(=O)NCCn3ccnc3)c2)cc1.
What is the InChIKey of 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide?
The InChIKey is CYCQYSQIDNJRHV-WIHCDAFUSA-N. The full InChI is InChI=1S/C37H39N5O8/c1-24-21-42(36(46)40-34(24)44)33-20-31(43)32(50-33)22-49-37(26-7-11-29(47-2)12-8-26,27-9-13-30(48-3)14-10-27)28-6-4-5-25(19-28)35(45)39-16-18-41-17-15-38-23-41/h4-15,17,19,21,23,31-33,43H,16,18,20,22H2,1-3H3,(H,39,45)(H,40,44,46)/t31-,32+,33+/m0/s1.
What are the key properties of 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide?
3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide has a molecular weight of 681.75 g/mol, XLogP of 3.15, 13 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-bis(4-methoxyphenyl)methyl]-N-(2-imidazol-1-ylethyl)benzamide is sourced from PubChem (CID 11115100), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).